125 related articles for article (PubMed ID: 8547714)
1. Quality control in immunophenotyping: U.S. efforts to establish common methodology and their impact. American Society for Histocompatibility and Immunogenetics.
Nicholson JK
Eur J Histochem; 1994; 38 Suppl 1():7-12. PubMed ID: 8547714
[TBL] [Abstract][Full Text] [Related]
2. More than just quality control.
Carey JL; Oldaker TA
Clin Lab Med; 2007 Sep; 27(3):687-707, ix. PubMed ID: 17658413
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the impact of a CD4+ T-cell testing laboratory improvement program.
Rosner E; Siragusa M; Schalla W; Cross D; Cohn R; Hearn T
Arch Pathol Lab Med; 1998 Jun; 122(6):512-9. PubMed ID: 9625418
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotyping specimens from HIV-infected persons: laboratory guidelines from the Centers for Disease Control and Prevention.
Nicholson JK
Cytometry; 1994 Mar; 18(1):55-9. PubMed ID: 7915984
[TBL] [Abstract][Full Text] [Related]
5. Nationwide quality control trial on lymphocyte immunophenotyping and flow cytometer performance in Italy.
Brando B; Sommaruga E
Cytometry; 1993; 14(3):294-306. PubMed ID: 8472606
[TBL] [Abstract][Full Text] [Related]
6. Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS.
Calvelli T; Denny TN; Paxton H; Gelman R; Kagan J
Cytometry; 1993 Oct; 14(7):702-15. PubMed ID: 8243200
[No Abstract] [Full Text] [Related]
7. CD4+ T-cell testing practices as implications for training.
Rosner E; Willis V; Lambert R; Latzanich G; Ponsell P
Cytometry; 1997 Aug; 30(4):181-5. PubMed ID: 9298836
[TBL] [Abstract][Full Text] [Related]
8. Assessment of interlaboratory variability of immunophenotyping. Results of the College of American Pathologists Flow Cytometry Survey.
Homburger HA; Rosenstock W; Paxton H; Paton ML; Landay AL
Ann N Y Acad Sci; 1993 Mar; 677():43-9. PubMed ID: 8494233
[No Abstract] [Full Text] [Related]
9. Analysis of the analytical performance of laboratories participating in two major U.S. bulk asbestos proficiency testing programs.
Harvey BW; Winstead WG
J Occup Environ Hyg; 2008 Jul; 5(7):455-62. PubMed ID: 18569508
[TBL] [Abstract][Full Text] [Related]
10. Centers for Disease Control programs in flow cytometric immunophenotyping.
Gerber AR
Ann N Y Acad Sci; 1993 Mar; 677():40-2. PubMed ID: 8388182
[No Abstract] [Full Text] [Related]
11. Flow cytometric lymphocyte subset enumeration: 10 years of external quality assessment in the Benelux countries.
Levering WH; van Wieringen WN; Kraan J; van Beers WA; Sintnicolaas K; van Rhenen DJ; Gratama JW
Cytometry B Clin Cytom; 2008 Mar; 74(2):79-90. PubMed ID: 17849485
[TBL] [Abstract][Full Text] [Related]
12. [Standardization in flow cytometry].
Tatsumi N; Kitahashi S; Kubota H; Tsuda I; Yasui Y; Tanaka K; Kondo H
Rinsho Byori; 1993 Sep; 41(9):982-9. PubMed ID: 8254976
[TBL] [Abstract][Full Text] [Related]
13. Improved precision in the enumeration of absolute numbers of lymphocyte phenotypes with long-term monthly proficiency testing.
Rickman WJ; Monical C; Waxdal MJ
Ann N Y Acad Sci; 1993 Mar; 677():53-8. PubMed ID: 8494246
[No Abstract] [Full Text] [Related]
14. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data reporting.
Braylan RC; Atwater SK; Diamond L; Hassett JM; Johnson M; Kidd PG; Leith C; Nguyen D
Cytometry; 1997 Oct; 30(5):245-8. PubMed ID: 9383098
[No Abstract] [Full Text] [Related]
15. Impact of the international program for Quality Assessment and Standardization for Immunological Measures Relevant to HIV/AIDS: QASI.
Mandy F; Bergeron M; Houle G; Bradley J; Fahey J
Cytometry; 2002 Apr; 50(2):111-6. PubMed ID: 12116353
[TBL] [Abstract][Full Text] [Related]
16. Are there differences between laboratories that use or fail to use the CDC's guidelines to measure CD4+ and CD8+ T cells?
Ferbas J; Logar AJ; Harwell TS
Cytometry; 1995 Sep; 22(3):256-7. PubMed ID: 8556958
[No Abstract] [Full Text] [Related]
17. Influence of 4- and 6-color flow cytometers and acquisition/analysis softwares on the determination of lymphocyte subsets in HIV infection.
Ashman M; Sachdeva N; Davila L; Scott G; Mitchell C; Cintron L; Rathore M; Asthana D
Cytometry B Clin Cytom; 2007 Sep; 72(5):380-6. PubMed ID: 17226862
[TBL] [Abstract][Full Text] [Related]
18. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: medical indications.
Davis BH; Foucar K; Szczarkowski W; Ball E; Witzig T; Foon KA; Wells D; Kotylo P; Johnson R; Hanson C; Bessman D
Cytometry; 1997 Oct; 30(5):249-63. PubMed ID: 9383099
[No Abstract] [Full Text] [Related]
19. 1997 revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV). Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1997 Jan; 46(RR-2):1-29. PubMed ID: 9011774
[TBL] [Abstract][Full Text] [Related]
20. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia.
Wood BL; Arroz M; Barnett D; DiGiuseppe J; Greig B; Kussick SJ; Oldaker T; Shenkin M; Stone E; Wallace P
Cytometry B Clin Cytom; 2007; 72 Suppl 1():S14-22. PubMed ID: 17803189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
